37 patents
Utility
Methods and formulations for reducing bovine emissions
9 Jan 24
The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof.
Cory T. Herr, John Charles Kube, Jerold Scott Teeter
Filed: 20 Apr 22
Utility
Feed additive compositions
2 May 23
The present disclosure provides feed composition comprising at least one cyclopropenoid fatty acids or at least one conjugated linoleic acid and at least one cyclopropenoid fatty acids with normal or basal feed.
Kim Friesen, Ran Song, Robert Musser
Filed: 24 Sep 18
Utility
Liquid composition containing pradofloxacin
4 Apr 23
The invention relates to pharmaceutical compositions in liquid form comprising pradofloxacin in an aqueous solution and citric acid or thioglycerol as antioxidants.
Iris Heep, Patrick Billian
Filed: 20 Aug 20
Utility
Wing protector for winged capsule and method of using same
28 Mar 23
An arrangement for delivery of a substance to an animal and a method of protection of a winged capsule.
Jianbin Li, Benjamin Jeffrey Cooper
Filed: 14 Aug 20
Utility
Porcine G-CSF variants and their uses
14 Feb 23
The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF).
Peter Connor Canning, Nickolas Knudsen, Md Harunur Rashid
Filed: 10 Oct 18
Utility
Quinoline derivatives
7 Feb 23
Walter Hübsch, Nils Griebenow, Hans-Georg Schwarz, Daniel Kulke, Claudia Böhm, Kirsten Börngen, Bernd Alig, Wei Zhuang, Iring Heisler, Thomas Ilg, Johannes Köbberling, Adeline Köhler, Niels Lindner, Ulrich Görgens, Claudia Welz, Maike Hink
Filed: 7 May 19
Utility
Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile
10 Jan 23
The present disclosure provides crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile, pharmaceutical compositions comprising the crystalline forms, methods of using the crystalline forms, and processes for making the crystalline forms.
Jingdan Hu, Timothy Andrew Woods
Filed: 22 Apr 20
Utility
Modified bovine G-CSF polypeptides and their uses
3 Jan 23
Modified bovine G-CSF polypeptides and uses thereof are provided.
Anna-Maria A. Hays Putnam, Nick Knudsen, Thea Norman, Alan Koder, Vadim Kraynov, Lillian Skidmore, Peter C. Canning
Filed: 19 Oct 18
Utility
Immunostimulatory compositions
3 Jan 23
The present disclosure relates to immunostimulatory compositions that are effective in eliciting immune responses in avian species.
Thomas Ilg
Filed: 7 Dec 18
Utility
Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
22 Nov 22
Florian Erver, Frank Memmel, Thomas Himmler, Andreas Karl Steib, Marc Nowakowski
Filed: 14 Dec 18
Utility
Anthelmintic quinoline-3-carboxamide derivatives
22 Nov 22
Walter Hübsch, Johannes Köbberling, Adeline Köhler, Hans-Georg Schwarz, Daniel Kulke, Claudia Welz, Thomas Ilg, Kirsten Börngen, Wei Zhuang, Nils Griebnow, Claudia Böhm, Niels Lindner, Maike Hink, Ulrich Görgens
Filed: 30 Oct 20
Utility
Azaquinoline derivatives
1 Nov 22
Nils Griebenow, Wei Zhuang, Adeline Köhler, Daniel Kulke, Claudia Böhm, Kirsten Börngen, Thomas Ilg, Hans-Georg Schwarz, Werner Hallenbach, Ulrich Görgens, Walter Hübsch, Bernd Alig, Iring Heisler, Isa Jana Irina Janssen
Filed: 22 Jun 18
Utility
Apparatus for fly management
11 Oct 22
The present invention relates to an apparatus (10) for fly management.
Veerle Hamaekers, Nazim Torun, Georg Berns
Filed: 21 May 19
Utility
Immunostimulatory compositions
20 Sep 22
The present disclosure relates to immunostimulatory compositions that are effective in eliciting immune responses in avian species.
Thomas Ilg
Filed: 7 Dec 18
Utility
Bovine respiratory disease vaccine
13 Sep 22
The present invention relates to vaccines for treating bovine respiratory disease.
Lucas Huntimer, Thomas Halbur
Filed: 27 Apr 18
Utility
Enhanced immune response in porcine species
13 Sep 22
The present invention generally relates to methods of eliciting an immune response in a porcine species subject.
Albert Abraham, Jason Nickell, Daniel Keil, Christian Weiss
Filed: 28 Jul 16
Utility
Markers to predict macrocyclic lactone drug resistance in
16 Aug 22
Disclosed are nucleic acid molecules from the genome of Dirofilaria spp. nematodes that contain single nucleotide polymorphisms related to reduced responsiveness of the nematodes to macrocyclic lactones.
Roger K. Prichard, Catherine Bourguinat, Timothy G. Geary
Filed: 2 Feb 18
Utility
Pharmaceutical preparation and method for its manufacture
12 Jul 22
The present invention refers to a pharmaceutical preparation (10) comprising a first pharmaceutical composition having a matrix material and pharmaceutically active ingredients distributed within the matrix material, wherein the first pharmaceutical composition comprises Praziquantel, Pyrantel and Febantel as pharmaceutical active ingredients, wherein the preparation (10) comprises a second pharmaceutical composition having a matrix material and at least one of avermectins and milbemycins such as Moxidectin as pharmaceutically active ingredient distributed within the matrix material, wherein the preparation (10) is provided in a multi-layer structure such, that the first composition is provided in a first layer (12) and the second composition is provided in a second layer (14), wherein the first layer (12) and the second layer (14) are separated by a barrier layer (16) being provided between the first layer (12) and the second layer (14).
Venkata-Rangarao Kanikanti, Patrick Billian
Filed: 30 Nov 17
Utility
Compounds for controlling arthropods
14 Jun 22
The present invention relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects and arachnids.
Joachim Telser, Ursula Krenz, Kirsten Boerngen, Andreas Turberg, Klein Sofia, Franziska Schmidt
Filed: 27 Jun 19
Utility
Methods and formulations for reducing bovine emissions
31 May 22
The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof.
Cory T. Herr, John Charles Kube, Jerold Scott Teeter
Filed: 3 Oct 16